Abstract:Introduction: Hyperactive catatonia is often unrecognized in pediatric patients due to its clinical heterogeneity, though it is often seen in children with neurodevelopmental disabilities, especially autism spectrum disorder (ASD). Emerging evidence implicates hyperactive catatonia in more cases of self-injury and aggression in ASD than previously thought. Objectives: The study seeks to describe cases of hyperactive catatonia in SYNGAP-1 mutation and examine existing literature for symptomatic overlap between previously-described clinical and behavioral phenotypes of individuals with SYNGAP-1 mutations and catatonia. Methods: The study describes two cases of an adolescent and a young adult with SYNGAP-1 mutation and ASD presenting with hyperactive catatonia, which are the first reports of catatonia in individuals known to have a pathogenic variant in SYNGAP-1. A systematic review was undertaken during which 101 articles were screened. 13 articles were then examined for neurological and behavioral features present in participants with SYNGAP-1 mutations which are seen in catatonia. Results: The systematic review demonstrates that clinical features suggestive of catatonia are frequently seen among individuals with SYNGAP-1 mutations, including verbal impairment, psychomotor symptoms, aggression, oral aversion, and incontinence. These features were also present in the cases of catatonia in SYNGAP-1 mutations presented here. Both patients showed clinical improvement with use of a long-acting benzodiazepine, and one patient showed benefit from electroconvulsive therapy. Conclusions: This symptomatic overlap revealed in the systematic review, including symptoms seen in the reported cases, raises the possibility that diagnoses of catatonia may have been missed in the past in individuals with SYNGAP-1 mutations. Self-injurious behavior and aggression, which are hallmarks of hyperactive catatonia, are commonly part of the behavioral phenotype of SYNGAP-1-related disorders. Clinicians should consider catatonia as a cause of such symptoms in individuals with SYNGAP-1 mutations, as effective treatment can result in significant improvement in safety and quality of life.

Atypical isolated cataplexy: two case reports and a mini-review

Sleepiness That Cannot Be Overcome: Narcolepsy And Cataplexy

Narcolepsy and pediatric acute-onset neuropsychiatric syndrome: A case report that suggests a putative link between the two disorders

Animal models of REM dysfunctions: what they tell us about the cause of narcolepsy and RBD?

SYNGAP-1 Mutation And Catatonia: A Case Series And Systematic Review

Advances in narcolepsy

Child Neurology: Common Occurrence of Narcolepsy Type 1 and Myasthenia Gravis

A Case of Narcolepsy Type 2 and Postural Tachycardia Syndrome Secondary to Lesions of the Thalamus and Amygdala

Case report: Diagnostic challenges in an adolescent case of autistic catatonia

Epilepsy and narcolepsy-cataplexy in a child.

Single cell transcriptomics of cerebrospinal fluid cells from patients with recent-onset narcolepsy

Case Report: Anti-NMDAR Encephalitis Presenting With Catatonic Symptoms in an Adolescent Female Patient With a History of Traumatic Exposure

Clinical heterogeneity associated with KCNA1 mutations include cataplexy and nonataxic presentations

Recent insights into the pathophysiology of narcolepsy type 1

A Unique Case of SCN2A Variant-Associated Catatonia and Response to Electroconvulsive Therapy

Neuropsychological Alterations in Narcolepsy with Cataplexy and the Expression of Cognitive Deficits

Hypnosis: An aid in working with patients with narcolepsy

The diagnosis and treatment of catatonia

Type 1 narcolepsy: a CD8(+) T cell-mediated disease?

Hypothalamic immunopathology in anti-Ma-associated diencephalitis with narcolepsy-cataplexy

Narcolepsy type 1 features across the life span: age impact on clinical and polysomnographic phenotype